ARPO
Aerpio Pharmaceuticals, Inc.
No insider bought or sold Aerpio Pharmaceuticals, Inc. in the last 12 months
ARPO over the last year
Prices for ARPO aren't in yet.
ARPO after insider buys
3 months after each buy, from the first price a copier could get.
No buys have 3 months of prices yet. A record shows here at 3.
Every filing
19 insider filings since 2018, newest first
Orbimed Advisors LLC · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Novartis Bioventures Ltd · 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Muneer A Satter · Director and 10% owner
Stephen J Hoffman · CEO
Chau Quang Khuong · Director and 10% owner
Orbimed Advisors LLC · Director and 10% owner
Muneer A Satter · Director and 10% owner
Filings come from SEC EDGAR and prices from daily closes. Not investment advice.